Latin American Consensus on the management of hypertension in the patient with diabetes and the metabolic syndrome
Why the study?
Prevalence of hypertension, DM2, and metabolic syndrome continues to increase in Latin America, while rates of diagnosis, treatment, and control remain low.
Design
Consensus document
Authors
Discussion
Loading...
Member takes
Implication
Persistent rises in hypertension, diabetes, and metabolic syndrome with low control in Latin America warrant vigilance; leaves open optimal regional strategies.
Structured PICO
P
Population
Patients with hypertension, type 2 diabetes mellitus (DM2), and metabolic syndrome in Latin America
I
Intervention
Management strategies including early pharmacological management of prediabetes with metformin, combination therapy of two fixed-dose antihypertensive drugs, statins, and polypill (angiotensin-converting enzyme inhibitor, statin, and aspirin)
This Latin American consensus provides updated recommendations for managing hypertension, diabetes, and metabolic syndrome, emphasizing early intervention, fixed-dose combinations, and polypill use to improve adherence and outcomes.
Cite This Study
López‐Jaramillo et al. (2019) studied this question.